301
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder

, , &
Pages 472-477 | Received 31 Oct 2019, Accepted 07 Mar 2020, Published online: 07 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhenhao Shi, Xinyi Li, Juliana I. Byanyima, Charles P. O’Brien, Anna Rose Childress, Kevin G. Lynch, James Loughead, Corinde E. Wiers & Daniel D. Langleben. (2023) Effects of current smoking severity on brain gray matter volume in opioid use disorder – a voxel-based morphometry study. The American Journal of Drug and Alcohol Abuse 49:2, pages 180-189.
Read now

Articles from other publishers (2)

Johannes Thrul, Jill A. Rabinowitz, Beth A. Reboussin, Brion S. Maher, James C. Anthony & Nicholas S. Ialongo. (2023) Longitudinal associations between age 20 problematic substance use and opioid use disorder incidence at age 30 – findings from an urban cohort. Journal of Psychiatric Research 160, pages 1-7.
Crossref
Hyoun S. Kim, David C. Hodgins, Ximena Garcia, Emma V. Ritchie, Iman Musani, Daniel S. McGrath & Kristin M. von Ranson. (2021) A systematic review of addiction substitution in recovery: Clinical lore or empirically-based?. Clinical Psychology Review 89, pages 102083.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.